The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The in vivo fate and effectiveness of a drug depends highly on its absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Organic anion transporting polypeptides (OATPs) are membrane proteins involved in the cellular uptake of various organic compounds, including clinically used drugs. Since OATPs are significant players in drug absorption and distribution, modulation of OATP function via pharmacotherapy with OATP substrates/inhibitors, or modulation of their expression, affects drug pharmacokinetics. Given their cancer-specific expression, OATPs may also be considered anticancer drug targets. Areas covered: We describe the human OATP family, discussing clinically relevant consequences of altered OATP function. We offer a critical analysis of published data on the role of OATPs in ADME and in drug-drug interactions, especially focusing on OATP1A2, 1B1, 1B3 and 2B1. Expert opinion: Four members of the OATP family, 1A2, 1B1, 1B3 and 2B1, have been characterized in detail. As biochemical and pharmacological knowledge on the other OATPs is lacking, it seems timely to direct research efforts towards developing the experimental framework needed to investigate the transport mechanism and substrate specificity of the poorly described OATPs. In addition, elucidating the role of OATPs in tumor development and therapy response are critical avenues for further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043 · cited 2×
“HIV (lopenavir), cancer (SN-38), allergy (fexofenadine), and immune diseases (tacrolimus) [5,160,161].”
BackgroundGodoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · cited 1×
“These models vary in maintenance costs, accessibility, and transporter expression pattern [144]; therefore, the appropriate models should be selected based on these considerations and the pharmacological goal.”
BackgroundSLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Pasanen, M. K., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230416.82349.90 · Cited by 470
Treiber, A., Schneiter, R., Häusler, S., & Stieger, B. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013615 · Cited by 299 · cited 3×
“direct sorafenib transport)[69] Anti-inflammatory drugs • direct mesalazine transport inhibited by budesonide, cyclosporine, rifampin [72] Antihypertensive drugs • direct bosentan uptake inhibited by CsA and rifampicin [70] • direct valsartan uptake [71] Toxins • direct microcystin transport and cytotoxicity [62,74] F…”
BackgroundHuman skeletal muscle drug transporters determine local exposure and toxicity of statins
Knauer, M. J., Urquhart, B. L., Meyer zu Schwabedissen, H. E., Schwarz, U. I., Lemke, C. J., Leake, B. F., Kim, R. B., & Tirona, R. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.203596 · Cited by 222 · cited 3×
“2A1 Ubiquitous: eye (retina, ciliary epithelium) [80] endometrium [122] neurons [123] Bile duct [124] bone [116] breast [114] liver [124] 2B1 Ubiquitous: BBB [113] intestine [96] liver (hepatocytes) [25] skeletal muscle [82] Apical (enterocytes) basolateral (hepatocytes) Breast* [114] Colon [50] bone [116] breast* [12…”
BackgroundElsby, R., Hilgendorf, C., & Fenner, K. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.163 · Cited by 198
Impact of genetic variation in OATP transporters to drug disposition and response
Gong, I. Y., & Kim, R. B. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rv-099 · Cited by 137
Gao, B., Vavricka, S. R., Meier, P. J., & Stieger, B. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1596-x · Cited by 100 · cited 5×
“1A2 Ubiquitous: BBB [112,113] eye (retina) [20,22] intestine [95] kidney (distal tubule) [112] liver (cholangiocytes) [112] neurons [22] Apical Breast* [114] colon [115] gliomas [113] Bone [116] breast*[43,117] prostate [118]”
BackgroundInfluentialArakawa, H., Nakanishi, T., Yanagihara, C., Nishimoto, T., Wakayama, T., Mizokami, A., Namiki, M., Kawai, K., & Tamai, I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.026 · Cited by 63
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Hladky, S. B., & Barrand, M. A. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0113-6 · Cited by 206
Takahashi, S., Karayama, M., Takahashi, M., Watanabe, J., Minami, H., Yamamoto, N., Kinoshita, I., Lin, C.-C., Im, Y.-H., Achiwa, I., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1560 · Cited by 37
Metadata
- Authors
- Kovacsics, D., Patik, I., & Özvegy-Laczka, C.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2016-11-09
- Volume
- 13
- Issue
- 4
- Pages
- 409-424
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2543434756
- Cited by
- 78
- References
- 9
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. https://app.cochat.ai/papers/10.1080/17425255.2017.1253679
- The paper
- Kovacsics, D., Patik, I., & Özvegy-Laczka, C. (2017). The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2017.1253679
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.